GLP-1 medications are reshaping obesity care and creating new opportunities to improve long-term health outcomes
Approved indication: Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
Excretion Following administration of an oral [14C] sitagliptin dose to healthy subjects, approximately 100% of the administered radioactivity was eliminated in feces (13%) or urine (87%) within one week of dosing
In certain embodiments, any controlled-release otic formulation described herein increases the exposure of an active agent and increases the Area Under the Curve (AUC) in otic fluids (e.g., endolymph and/or perilymph) by about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 100%, or higher than 100%, compared to an otic formulation that is not a controlled-release otic formulation
Your body treats connection like therapy it can measure
Injection timing offers more flexibility than oral protocols